Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 3/20 | 0.38 |
| ▸ | GPR119 | Q8TDV5 | 8/20 | 0.36 |
| ▸ | CYP4F2 | P78329 | 4/20 | 0.35 |
| ▸ | CYP4A11 | Q02928 | 4/20 | 0.35 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.34 |
| ▸ | FEN1 | P39748 | 1/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.33 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.33 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16757857 | 1.00 | CNR2 (0.38) | CNR2GPR119CYP4F2CYP4A11ALOX5AP | |
| SCHEMBL16757861 | 1.00 | CNR2 (0.38) | CNR2GPR119CYP4F2CYP4A11ALOX5AP | |
| SCHEMBL18842778 | 0.94 | GPR119 (0.39) | CNR2GPR119CYP4F2CYP4A11ALOX5AP | |
| SCHEMBL18842772 | 0.94 | CNR2 (0.39) | CNR2GPR119CYP4F2CYP4A11ALOX5AP | |
| SCHEMBL18842789 | 0.94 | CNR2 (0.39) | CNR2GPR119CYP4F2CYP4A11ALOX5AP | |
| SCHEMBL16758055 | 0.93 | CNR2 (0.39) | CNR2GPR119CYP4F2CYP4A11 | |
| SCHEMBL16758060 | 0.93 | CNR2 (0.39) | CNR2GPR119CYP4F2CYP4A11 | |
| SCHEMBL16758176 | 0.92 | CNR2 (0.38) | CNR2GPR119CYP4F2CYP4A11ROCK2 | |
| SCHEMBL16758174 | 0.92 | CNR2 (0.38) | CNR2GPR119CYP4F2CYP4A11ROCK2 | |
| SCHEMBL16769022 | 0.89 | GPR119 (0.46) | CNR2GPR119CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9776987-B2 | Amide derivatives for GPR119 agonist | CHONG KUN DANG PHARMACEUTICAL CORP (KR) | 2017-10-03 | — | — | US | disclosed |
| US-20170129875-A1 | AMIDE DERIVATIVES FOR GPR119 AGONIST | CHONG KUN DANG PHARMACEUTICAL CORP. (KR) | 2017-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170129875-A1 | AMIDE DERIVATIVES FOR GPR119 AGONIST | GPR119, FFAR2, GLP1R | CNR2 35/4885GPR119 1/4885CYP4F2 1388/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.